Related people
Kathleen Munstermann is an expert in regulatory healthcare law.
She focuses on advising on the regulatory aspects of complex transactions in the healthcare sector, in particular on the establishment and acquisition of healthcare facilities such as medical practices, medical care centers (MVZ), outpatient and inpatient rehabilitation facilities as well as (private) clinics. This includes the structuring, management and implementation of regulatory application procedures and contract negotiations as well as the timing synchronization of approval procedures and acquisition process.
Kathleen Munstermann also advises on the strategic orientation, the development of innovative cooperation and care provision models as well as on the intersectoral linking of outpatient and inpatient medical service provision. In addition to the law of the Statuory Helath Insurance Scheme she advises on medical professional law as well as on issues of digitalization in the healthcare sector and compliance.
Another focus is on advising on care transactions (nursing homes, assisted living, care real estate, outpatient care, intensive care).
Since 2021 | Salary Partner, Taylor Wessing |
2019 – 2021 | Senior Associate, Taylor Wessing |
2016 – 2019 | Associate, Taylor Wessing |
2018 | Lecturer in health management for pharmaceutical, medical device and competition law as well as the professional law of the health professions, University of Aalen |
2013 | Legal clerkship, OLG Celle |
2016 – 2017 | LL.M. (Medizinrecht), Heinrich–Heine–University Düsseldorf |
2016 | Admitted as a lawyer |
2015 | Second state examination |
2013 | First state examination |
Kommentar: Die Zukunft der außerklinischen Intensivpflege, in: Health & Care Management, 2/2021 Konzentrationsbewegungen im Pflegemarkt – Herausforderungen sehen, Chancen nutzen, in: KU Gesundheitsmanagement, 7/2020 Gastbeitrag – Rechtswidrige Sperren, in: sgp REPORT, 16/2019 |
English, Norwegian |
Latest news & insights
Taylor Wessing advises NORD Holding and Zentrum Gesundheit on the acquisition of Klinik Flechsig
by multiple authors
Draft of a cannabis law for the further legalisation of cannabis in Germany
Legal requirements for green claims in advertising for medical devices
by Dr. Daniel Tietjen and Sherin Sayed
Patenting AI-generated inventions – is patent law acting the luddite?